Effect of Simvastatin Administration on ALP (Alkaline Phosphatase) Level in Wistar Rat's Femur Fracture
DOI:
https://doi.org/10.21776/ub.jkb.2022.032.02.2Keywords:
Alkaline phosphate, femur fracture, simvastatinAbstract
Metabolism of the bone healing process can be monitored by Bone formation marker, such as alkaline phosphate (ALP). Simvastatin is known to increase bone marker formation in the repair phase, but its effects on the ALP level have not been known yet. This study aimed to determine the effect of oral simvastatin administration on the expression of ALP level in femur fracture healing in a rat model of femur fracture. The research method was experimental post-test only using 18 Rattus norvegicus rats which were divided into 3 groups, namely the control group for femur fracture (Control), femoral fracture group and giving simvastatin 0.36 mg/day for 2 weeks (Treatment I), and femur fracture group and administration of simvastatin 0.36 mg/day for 4 weeks (Treatment II). ALP levels were measured at 0, 2, and 4 weeks. The results showed an increase in ALP levels in the simvastatin treatment group compared to the control group (p<0.05). It can be concluded that the administration of simvastatin increased ALP levels in rat femoral fractures.
Downloads
References
Badan Pusat Statistik. Jumlah Kecelakaan, Koban Mati, Luka Berat, Luka Ringan, dan Kerugian Materi yang Diderita Tahun 1992-2013. (Online) 2012. https://www.bps.go.id/linkTabelStatis/view/id/1415.
Lubis I, Rahmat M, and Rahardjo. Akibat Aplikasi Simvastatin pada Proses Penyembuhan Tulang terhadap Ekspresi Kolagen Tipe I (Pada Binatang Coba Tikus Diabetes Melitus Tipe 1). Jurnal Kedokteran Gigi. 2015: 6(4): 340-346.
Elgali I, Omar O, Dahlin C, and Thomsen P. Guided Bone Regeneration: Materials and Biological Mechanisms Revisited. European Journal of Oral Sciences. 2017; 125(5): 315-337.
Abdul-Majeed S, Mohamed N, and Soelaiman IN. Effects of Tocotrienol and Lovastatin Combination on Osteoblast and Osteoclast Activity in Estrogen-Deficient Osteoporosis. Evidence-Based Complementary and Alternative Medicine. 2012; 2012: 1-9.
Chen PY, Sun JS, Tsuang YH, Chen MH, Weng PW, and Lin FH. Simvastatin Promotes Osteoblast Viability and Differentiation via Ras/Smad/Erk/BMP-2 Signaling Pathway. Nutrition Research. 2010; 30(3): 191–199.
Rostiny R, Djulaeha E, Hendrijantini N, and Pudijanto A. The Effect of Combined Moringa oleifera and Demineralized Freeze-Dried Bovine Bone Xenograft on the Amount of Osteoblast and Osteoclast in the Healing of Tooth Extraction Socket of Cavia cobaya. Dental Journal. 2016: 49(1); 38-43.
Witkowsa-Sedek E, Stelmaszczyk-Emmel A, Majcher A, Demkow U, and Pyrzak B. The Relationships of Alkaline Phosphatase and Bone Alkaline Phosphatase to the Growth Hormone/Insulin-like Growth Factor-1 Axis an Vitamin D Status in Children with Growth Hormone Deficiency. Acta Biochimica Polonica. 2018; 65(2): 269-275.
Wong SK, Chin KY, Suhaimi FH, Ahmad F, and Ima-Nirwana S. The Relationship between Metabolic Syndrome and Osteoporosis: A Review. Nutrients. 2016: 8(6): 1 –18.
Viccica G, Francucci CM, and Marcocci C. The Role of PPARγ for the Osteoblastic Differentiation. Journal of Endocrinological Investigation. 2010; 33(7): 9–12.
Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, and Vergely C. The Role of Osteoprotegerin in the Crosstalk between Vessels and Bone: Its Potential Utility as a Marker of Cardiometabolic Diseases. Pharmacology & Therapeutics. 2018; 182: 115-132.
Zhang Y, Bradley AD, Wang D, and Reinhardt RA. Statins, Bone Metabolism and Treatment of Bone Catabolic Diseases. Pharmacological Research. 2014; 88: 53-61.
Oryan A, Kamali A, and Moshiri A. Potential Mechanisms and Applications of Statins on Osteogenesis: Current Modalities, Conflicts and Future Directions. Journal of Controlled Release. 2015; 215: 12-24.
Han G, Chen YP, Hou J, et al. Effects of Simvastatin on Relapse and Remodeling of Periodontal Tissues after Tooth Movement in Rats. American Journal of Orthodontics and Dentofacial Orthopedics. 2010; 138(5): 550-551.
Jadhav SB, Murthy PSN, Singh MM, and Jain GK. Distribution of Lovastatin to Bone and Its Effect on Bone Turnover in Rats. The Journal of Pharmacy and Pharmacology. 2006; 58(11): 1451–1458.
Nelson E, Wardell S, and McDonnell DP. The Molecular Mechanisms Underlying the Pharmacological Actions of Estrogens, SERMs and Oxysterols: Implications for the Treatment and Prevention of Osteoporosis. Bone. 2013; 53(1): 42-50.
Gentile P, Nandagiri VK, Daly J, et al. Localised Controlled Release of Simvastatin from Porous Chitosan-Gelatin Scaffold Engrafted with Simvastatin Loaded PLGA-microparticles for Bone Tissue Engineering Application. Materials Science & Engineering. C, Materials for Biological Applications. 2016; 59: 249-257.
Downloads
Published
Versions
- 2022-11-21 (3)
- 2022-11-04 (2)
- 2022-08-31 (1)
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
